{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:18:08Z","timestamp":1762157888525,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Mesothelioma is a rare cancer with disproportionately higher death rates for shipping and mining populations. These patients have few treatment options, which can be partially attributed to limited chemotherapy responses for tumors. We initially hypothesized that quinacrine could be combined with cisplatin or pemetrexed to synergistically eliminate mesothelioma cells. The combination with cisplatin resulted in synergistic cell death and the combination with pemetrexed was not synergistic, although novel artificially-generated pemetrexed-resistant cells were more sensitive to quinacrine. Unexpectedly, we discovered cells with NF2 mutations were very sensitive to quinacrine. This change of quinacrine sensitivity was confirmed by NF2 ectopic expression and knockdown in NF2 mutant and wildtype cell lines, respectively. There are few common mutations in mesothelioma and inactivating NF2 mutations are present in up to 60% of these tumors. We found quinacrine alters the expression of over 3000 genes in NF2-mutated cells that were significantly different than quinacrine-induced changes in NF2 wildtype cells. Changes to NF2\/hippo pathway biomarkers were validated at the mRNA and protein levels. Additionally, quinacrine induces a G1 phase cell cycle arrest in NF2-mutated cells versus the S phase arrest in NF2-wildtype cells. This study suggests quinacrine may have repurposing potential for a large subset of mesothelioma patients.<\/jats:p>","DOI":"10.3389\/fphar.2021.750352","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T06:55:12Z","timestamp":1632207312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations"],"prefix":"10.3389","volume":"12","author":[{"given":"Derek B.","family":"Oien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayantani","family":"Sarkar Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viji","family":"Shridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python Framework to Work with High-Throughput Sequencing Data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.molonc.2016.09.005","article-title":"VCP Inhibitors Induce Endoplasmic Reticulum Stress, Cause Cell Cycle Arrest, Trigger Caspase-Mediated Cell Death and Synergistically Kill Ovarian Cancer Cells in Combination with Salubrinal","volume":"10","author":"Bastola","year":"2016","journal-title":"Mol. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10637-017-0515-3","article-title":"Phase I Study of the Combination of Quinacrine and Erlotinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer","volume":"36","author":"Bhateja","year":"2018","journal-title":"Invest. New Drugs"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.91752","article-title":"Emerging Drug Therapies for Mesothelioma","author":"B. Oien","year":"2020","journal-title":"IntechOpen"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.1038\/s41598-021-86834-7","article-title":"Transcriptional Perturbation of Protein Arginine Methyltransferase-5 Exhibits MTAP-Selective Oncosuppression","volume":"11","author":"Busacca","year":"2021","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: Scientific Clues for Prevention, Diagnosis, and Therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.can-09-1947","article-title":"Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/archinte.1954.00250010137011","article-title":"Quinacrine (Atabrine) in Treatment of Systemic and Discoid Lupus Erythematosus","volume":"94","author":"Dubois","year":"1954","journal-title":"AMA Arch. Intern. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/rhe1.1958.4.issue-1-4.04","article-title":"Treatment of Rheumatoid Arthritis with Quinacrine and Chloroquine","volume":"4","author":"Engeset","year":"1958","journal-title":"Acta Rheumatol. Scand."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1038\/bcj.2015.31","article-title":"Drug Screen in Patient Cells Suggests Quinacrine to Be Repositioned for Treatment of Acute Myeloid Leukemia","volume":"5","author":"Eriksson","year":"2015","journal-title":"Blood Cancer J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/sj.bjp.0706072","article-title":"A Possible Pharmacological Explanation for Quinacrine Failure to Treat Prion Diseases: Pharmacokinetic Investigations in a Ovine Model of Scrapie","volume":"144","author":"Gayrard","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2217\/fon.09.127","article-title":"New Hopes from Old Drugs: Revisiting DNA-Binding Small Molecules as Anticancer Agents","volume":"5","author":"Gurova","year":"2009","journal-title":"Future Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17448","DOI":"10.1073\/pnas.0508888102","article-title":"Small Molecules that Reactivate P53 in Renal Cell Carcinoma Reveal a NF-kappaB-dependent Mechanism of P53 Suppression in Tumors","volume":"102","author":"Gurova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ijc.27611","article-title":"SOCS-1 Gene Delivery Cooperates with Cisplatin Plus Pemetrexed to Exhibit Preclinical Antitumor Activity against Malignant Pleural Mesothelioma","volume":"132","author":"Iwahori","year":"2013","journal-title":"Int. J. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.4049\/jimmunol.171.10.5051","article-title":"IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells that Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: a Novel Mechanism for IL-2","volume":"171","author":"Jackaman","year":"2003","journal-title":"J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1038\/s41598-018-20531-w","article-title":"Quinacrine Upregulates P21\/p27 Independent of P53 through Autophagy-Mediated Downregulation of P62-Skp2 axis in Ovarian Cancer","volume":"8","author":"Jung","year":"2018","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ygyno.2017.04.022","article-title":"Quinacrine in Endometrial Cancer: Repurposing an Old Antimalarial Drug","volume":"146","author":"Kalogera","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: Integrating Viruses and Cellular Organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"36354","DOI":"10.18632\/oncotarget.5632","article-title":"Quinacrine Promotes Autophagic Cell Death and Chemosensitivity in Ovarian Cancer and Attenuates Tumor Growth","volume":"6","author":"Khurana","year":"2015","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176306","article-title":"Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation","volume":"21","author":"Kulkarni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3389\/fonc.2019.00986","article-title":"Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer","volume":"9","author":"Kumar","year":"2019","journal-title":"Front. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.taap.2018.04.008","article-title":"Mesothelioma and Other Lung Disease in Taconite Miners; the Uncertain Role of Non-asbestiform EMP","volume":"361","author":"Mandel","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3727\/096504012x13473664562628","article-title":"Quinacrine-mediated Autophagy and Apoptosis in colon Cancer Cells Is through a P53- and P21-dependent Mechanism","volume":"20","author":"Mohapatra","year":"2012","journal-title":"Oncol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The Emerging Roles of YAP and TAZ in Cancer","volume":"15","author":"Moroishi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/0008-5472.can-10-2164","article-title":"LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma","volume":"71","author":"Murakami","year":"2011","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ Signaling and Resistance to Cancer Therapy","volume":"5","author":"Nguyen","year":"2019","journal-title":"Trends Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3389\/fphar.2017.00970","article-title":"Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy","volume":"8","author":"Oien","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2019.09.021","article-title":"Repurposing Quinacrine for Treatment-Refractory Cancer","volume":"68","author":"Oien","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/1541-7786.mcr-17-0511","article-title":"Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of P-Chk1\/2 in P53-Negative Malignant Cancers","volume":"16","author":"Park","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-m","article-title":"Characteristics of Nine Newly Derived Mesothelioma Cell Lines","volume":"59","author":"Pass","year":"1995","journal-title":"Ann. Thorac. Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ijc.26158","article-title":"Quinacrine Has Anticancer Activity in Breast Cancer Cells through Inhibition of Topoisomerase Activity","volume":"130","author":"Preet","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41419-019-1916-3","article-title":"PFKFB3 Inhibition Reprograms Malignant Pleural Mesothelioma to Nutrient Stress-Induced Macropinocytosis and ER Stress as Independent Binary Adaptive Responses","volume":"10","author":"Sarkar Bhattacharya","year":"2019","journal-title":"Cell Death Dis."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040988","article-title":"NF2\/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma","volume":"19","author":"Sato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0169-5002(95)90162-0","article-title":"Neurofibromatosis Type 2 (NF2) Gene Is Somatically Mutated in Mesothelioma but Not in Lung Cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/117693510700300022","article-title":"Analysis of Gene Expression Data Using BRB-ArrayTools","volume":"3","author":"Simon","year":"2007","journal-title":"Cancer Inform."},{"key":"B38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1535-7163.mct-20-0717","article-title":"Small Molecule Inhibitors of TEAD Auto-Palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-Deficient Mesothelioma","volume":"20","author":"Tang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/cancers13092004","article-title":"Quinacrine-Induced Autophagy in Ovarian Cancer Triggers Cathepsin-L Mediated Lysosomal\/Mitochondrial Membrane Permeabilization and Cell Death","volume":"13","author":"Thirusangu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential Gene and Transcript Expression Analysis of RNA-Seq Experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/jco.2003.11.136","article-title":"Phase III Study of Pemetrexed in Combination with Cisplatin versus Cisplatin Alone in Patients with Malignant Pleural Mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-activated Kinase Links Rac\/Cdc42 Signaling to merlin","volume":"277","author":"Xiao","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.750352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T06:55:15Z","timestamp":1632207315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.750352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":42,"alternative-id":["10.3389\/fphar.2021.750352"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.750352","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"article-number":"750352"}}